SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
about
Checkpoint Inhibitors and Their Application in Breast CancerCurrent status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapyImpact of carbon nanotubes and graphene on immune cellsApplication of carbon nanotubes layered on silicon wafer for the detection of breast cancer marker carbohydrate antigen 15-3 by immuno-polymerase chain reaction.Preamble to the 2015 SITC immunotherapy biomarkers taskforceEvaluation of SLOG/TCI-III pediatric system on target control infusion of propofol.The immune-related role of BRAF in melanoma.Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens.Immune cell impact of three differently coated lipid nanocapsules: pluronic, chitosan and polyethylene glycolCXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2.Ipilimumab: its potential in non-small cell lung cancer.Harnessing the immune system for the treatment of melanoma: current status and future prospects.The perception of nanotechnology and nanomedicine: a worldwide social media study.YB-1 immunization combined with regulatory T-cell depletion induces specific T-cell responses that protect against neuroblastoma in the early stage.Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols.The Society for Immunotherapy of Cancer Biomarkers Task Force recommendations review.
P2860
Q26745442-EE6B18EE-3F3F-45A9-81A6-F86D84928721Q26745516-C6957B98-3886-46F3-8379-00CB39E8B072Q28388540-7D648E95-AC8A-4A54-A08C-1D8370611D9AQ35002966-CCA6B791-4E64-441F-A314-85B394433AAEQ35212166-56B9B97D-2B15-400F-AF2A-734FCDC86910Q35565974-FAB3C663-5DEF-4232-B6A1-825B74F2538BQ35847321-D2D2331A-A6F2-489C-BD91-013C92D310D9Q36112645-290F4F23-5A33-426B-871D-EBDF4C0827A7Q36427935-F316490A-A1BF-4D41-91C3-7864B1ABF814Q37279217-7032222F-199F-4159-A6ED-314EB9CACD3EQ37994189-E47303C3-DE96-4055-8387-7A2FA2B37EB0Q38806243-91C3B3BE-25C3-40A6-AA63-0F074A833662Q39123699-CD910D6B-9951-4B4E-817C-4694687048A2Q39241485-266C48D7-79D5-47FF-9292-E6A23EB340EEQ39784050-91BD2093-53A0-4E57-B182-495D7582893BQ49885285-062FA262-8D31-4B42-87CE-D4ECAF841BCE
P2860
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@ast
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@en
type
label
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@ast
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@en
prefLabel
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@ast
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@en
P2093
P2860
P356
P1476
SITC/iSBTc Cancer Immunotherap ...... he land of biomarker discovery
@en
P2093
Bernard A Fox
Cedrik M Britten
Francesco M Marincola
James M Balwit
Lucia G Delogu
Mary L Disis
Sara Tomei
Thomas F Gajewski
P2860
P2888
P356
10.1186/1479-5876-9-155
P577
2011-09-19T00:00:00Z
P5875
P6179
1036476842